Literature DB >> 9753016

Estimating sensitivity and sojourn time in screening for colorectal cancer: a comparison of statistical approaches.

T C Prevost1, G Launoy, S W Duffy, H H Chen.   

Abstract

The effectiveness of cancer screening depends crucially on two elements: the sojourn time (that is, the duration of the preclinical screen-detectable period) and the sensitivity of the screening test. Previous literature on methods of estimating mean sojourn time and sensitivity has largely concentrated on breast cancer screening. Screening for colorectal cancer has been shown to be effective in randomized trials, but there is little literature on the estimation of sojourn time and sensitivity. It would be interesting to demonstrate whether methods commonly used in breast cancer screening could be used in colorectal cancer screening. In this paper, the authors consider various analytic strategies for fitting exponential models to data from a screening program for colorectal cancer conducted in Calvados, France, between 1991 and 1994. The models yielded estimates of mean sojourn time of approximately 2 years for 45- to 54-year-olds, 3 years for 55- to 64-year-olds, and 6 years for 65- to 74-year-olds. Estimates of sensitivity were approximately 75%, 50%, and 40% for persons aged 45-54, 55-64, and 65-74 years, respectively. There is room for improvement in all models in terms of goodness of fit, particularly for the first year after screening, but results from randomized trials indicate that the sensitivity estimates are roughly correct.

Entities:  

Mesh:

Year:  1998        PMID: 9753016     DOI: 10.1093/oxfordjournals.aje.a009687

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  18 in total

1.  Dietary patterns and risk of colorectal tumors: a cohort of French women of the National Education System (E3N).

Authors:  E Kesse; F Clavel-Chapelon; M C Boutron-Ruault
Journal:  Am J Epidemiol       Date:  2006-09-21       Impact factor: 4.897

2.  Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths.

Authors:  Ann G Zauber; Sidney J Winawer; Michael J O'Brien; Iris Lansdorp-Vogelaar; Marjolein van Ballegooijen; Benjamin F Hankey; Weiji Shi; John H Bond; Melvin Schapiro; Joel F Panish; Edward T Stewart; Jerome D Waye
Journal:  N Engl J Med       Date:  2012-02-23       Impact factor: 91.245

3.  Estimating key parameters in FOBT screening for colorectal cancer.

Authors:  Dongfeng Wu; Diane Erwin; Gary L Rosner
Journal:  Cancer Causes Control       Date:  2008-08-15       Impact factor: 2.506

4.  Estimated mean sojourn time associated with hemoccult SENSA for detection of proximal and distal colorectal cancer.

Authors:  Wenying Zheng; Carolyn M Rutter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-08-21       Impact factor: 4.254

5.  A projection of benefits due to fecal occult blood test for colorectal cancer.

Authors:  Dongfeng Wu; Diane Erwin; Gary L Rosner
Journal:  Cancer Epidemiol       Date:  2009-09-04       Impact factor: 2.984

6.  Baseline and annual repeat rounds of screening: implications for optimal regimens of screening.

Authors:  Claudia I Henschke; Mary Salvatore; Matthew Cham; Charles A Powell; Larry DiFabrizio; Raja Flores; Andrew Kaufman; Corey Eber; Rowena Yip; David F Yankelevitz
Journal:  Eur Radiol       Date:  2017-10-05       Impact factor: 5.315

7.  Surveillance for Hepatocellular Carcinoma Also Improves Survival of Incidentally Detected Intrahepatic Cholangiocarcinoma Arisen in Liver Cirrhosis.

Authors:  Francesco Tovoli; Pietro Guerra; Massimo Iavarone; Letizia Veronese; Matteo Renzulli; Stefania De Lorenzo; Francesca Benevento; Giovanni Brandi; Federico Stefanini; Fabio Piscaglia
Journal:  Liver Cancer       Date:  2020-10-28       Impact factor: 11.740

8.  Evaluating risk factor assumptions: a simulation-based approach.

Authors:  Carolyn M Rutter; Diana L Miglioretti; James E Savarino
Journal:  BMC Med Inform Decis Mak       Date:  2011-09-07       Impact factor: 2.796

9.  Parameter estimates for invasive breast cancer progression in the Canadian National Breast Screening Study.

Authors:  S Taghipour; D Banjevic; A B Miller; N Montgomery; A K S Jardine; B J Harvey
Journal:  Br J Cancer       Date:  2013-01-15       Impact factor: 7.640

10.  Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme.

Authors:  Szu-Min Peng; Wen-Feng Hsu; Ying-Wei Wang; Li-Ju Lin; Amy Ming-Fang Yen; Li-Sheng Chen; Yi-Chia Lee; Ming-Shiang Wu; Tony Hsiu-Hsi Chen; Han-Mo Chiu
Journal:  Gut       Date:  2020-09-28       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.